What's breaking now, across thousands of outlets.
Vertex is betting on nephrology and rare endocrinology to build a fifth and fourth commercial pillar beyond cystic fibrosis.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
Africa’s crypto adoption has surged, moving rapidly from speculation to real-world utility like cross-border payments. As demand grows, the continent's next challenge is establishing the reliable…
Apple is trading lower following its fiscal fourth quarter earnings report, but analysts say that there are several reasons to still be bullish on the stock.
Versant Media said third quarter profit fell as its dependence on traditional media properties forced it to navigate with drops in cash from both advertising and distribution even as the company…
Dividend investors seek out companies that can raise their payouts consistently each year.
